Advanced tests for skin and respiratory sensitization assessment.

Sens-it-iv is an FP6 Integrated Project that finished in March 2011 after 66 months of activity, thanks to 12 million € of funding. The ultimate goal of the Sens-it-iv project was the development of a set of in vitro methods for the assessment of the skin and respiratory sensitization potential of chemicals and proteins. The level of development was intended to be at the point to enter the pre-validation phase. At the end of the project it can be concluded that the goal has been largely accomplished. Several advanced methods were evaluated extensively, and for some of them a detailed Standard Operating Procedure (SOP) was established. Other, less advanced methods also contributed to our understanding of the mechanisms driving sensitization. The present contribution, which has been prepared with the support of CAAT-Europe, represents a short summary of what was discussed during the 3-day end congress of the Sens-it-iv project in Brussels. It presents a list of methods that are ready for skin sensitization hazard assessment. Potency evaluation and the possibility of distinguishing skin from respiratory sensitizers are also well advanced.

[1]  J. Nicolas,et al.  Effector and regulatory mechanisms in allergic contact dermatitis , 2009, Allergy.

[2]  Marina Marinovich,et al.  Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[3]  Mardas Daneshian,et al.  The Center for Alternatives to Animal Testing - Europe (CAAT-EU): a transatlantic bridge for the paradigm shift in toxicology. , 2010, ALTEX.

[4]  Valérie Zuang,et al.  A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.

[5]  Silvia Casati,et al.  Management of an Integrated Project (Sens-it-iv) to Develop In Vitro Tests to Assess Sensitisation , 2007, Alternatives to laboratory animals : ATLA.

[6]  M. Goebeler,et al.  The contact allergen nickel sensitizes primary human endothelial cells and keratinocytes to TRAIL-mediated apoptosis , 2009, Journal of cellular and molecular medicine.

[7]  R. Berliner.  Active Transport , 1964, Physiology for physicians.

[8]  Andrea Cavani,et al.  Human T cell priming assay (hTCPA) for the identification of contact allergens based on naive T cells and DC--IFN-γ and TNF-α readout. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  G Frank Gerberick,et al.  Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  E. Corsini,et al.  Use of IL-8 release and p38 MAPK activation in THP-1 cells to identify allergens and to assess their potency in vitro. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  J.,et al.  Inter-laboratory study of the in vitro DC migration assay for 1 identification of contact allergens , 2012 .

[12]  Friedrich Herberg,et al.  Metal-Protein Complex-Mediated Transport and Delivery of Ni2+ to TCR/MHC Contact Sites in Nickel-Specific Human T Cell Activation1 , 2004, The Journal of Immunology.

[13]  S. Spiekstra,et al.  A potential in vitro epidermal equivalent assay to determine sensitizer potency. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[14]  K Ouwehand,et al.  Inter-laboratory study of the in vitro dendritic cell migration assay for identification of contact allergens. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[15]  Thomas Vogl,et al.  Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel , 2010, Nature Immunology.

[16]  H. Behrendt,et al.  CD56highCD16−CD62L− NK Cells Accumulate in Allergic Contact Dermatitis and Contribute to the Expression of Allergic Responses , 2009, The Journal of Immunology.

[17]  J. Hooyberghs,et al.  Functionality and specificity of gene markers for skin sensitization in dendritic cells. , 2011, Toxicology letters.

[18]  B. Igyártó,et al.  Early immune events in the induction of allergic contact dermatitis , 2012, Nature Reviews Immunology.

[19]  Susan Gibbs,et al.  Technical Advance: Langerhans cells derived from a human cell line in a full‐thickness skin equivalent undergo allergen‐induced maturation and migration , 2011, Journal of leukocyte biology.

[20]  W. Schamel,et al.  Subproteomic analysis of metal‐interacting proteins in human B cells , 2005, Proteomics.

[21]  Emanuela Corsini,et al.  Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 to determine the skin sensitizing capacity and epidermal equivalent assay to determine sensitizer potency. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[22]  L. Dietz,et al.  Proteomic allergen-peptide/protein interaction assay for the identification of human skin sensitizers. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[23]  G Frank Gerberick,et al.  Development of a peptide reactivity assay for screening contact allergens. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  J. E. Wraith.  Clinical aspects and diagnosis , 2004 .

[25]  P. Blackshear.  Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. , 2001, Biochemical Society transactions.

[26]  Petra Kern,et al.  Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment. , 2011, ALTEX.

[27]  K. Reisinger,et al.  Identifying and characterizing chemical skin sensitizers without animal testing: Colipa's research and method development program. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[28]  Andreas Luch,et al.  T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays , 2010, Cellular and Molecular Life Sciences.

[29]  S. Frankenberg,et al.  Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. , 2001, The Journal of investigative dermatology.

[30]  J. Hooyberghs,et al.  Microarray analyses in dendritic cells reveal potential biomarkers for chemical-induced skin sensitization. , 2007, Molecular immunology.

[31]  M. Goebeler,et al.  Metal allergens nickel and cobalt facilitate TLR4 homodimerization independently of MD2 , 2012, EMBO reports.

[32]  Marina Marinovich,et al.  Isoeugenol destabilizes IL-8 mRNA expression in THP-1 cells through induction of the negative regulator of mRNA stability tristetraprolin , 2011, Archives of Toxicology.

[33]  H. Merk,et al.  Active transport of contact allergens in human monocyte-derived dendritic cells is mediated by multidrug resistance related proteins. , 2011, Archives of biochemistry and biophysics.

[34]  N. Krug,et al.  Natural innate cytokine response to immunomodulators and adjuvants in human precision-cut lung slices. , 2010, Toxicology and applied pharmacology.

[35]  C L Galli,et al.  Further development of the NCTC 2544 IL-18 assay to identify in vitro contact allergens. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[36]  A. Anel,et al.  Quantitative DY‐maleimide‐based proteomic 2‐DE‐labeling strategies using human skin proteins , 2009, Proteomics.

[37]  T. D. de Gruijl,et al.  CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis , 2008, European journal of immunology.

[38]  R J Scheper,et al.  Potential method to determine irritant potency in vitro - Comparison of two reconstructed epidermal culture models with different barrier competency. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[39]  K. Landsteiner,et al.  STUDIES ON THE SENSITIZATION OF ANIMALS WITH SIMPLE CHEMICAL COMPOUNDS , 1935, The Journal of experimental medicine.

[40]  H. Merk,et al.  High-Resolution Transcriptional Profiling of Chemical-Stimulated Dendritic Cells Identifies Immunogenic Contact Allergens, but Not Prohaptens , 2010, Skin Pharmacology and Physiology.

[41]  A cell-based in vitro alternative to identify skin sensitizers by gene expression , 2008 .

[42]  F. Bérard,et al.  CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. , 2006, The Journal of investigative dermatology.

[43]  Petra S Kern,et al.  Integrating non-animal test information into an adaptive testing strategy - skin sensitization proof of concept case. , 2011, ALTEX.

[44]  Stefan F Martin,et al.  Contact dermatitis: from pathomechanisms to immunotoxicology , 2012, Experimental dermatology.

[45]  Ian Kimber,et al.  IL‐18 is a key proximal mediator of contact hypersensitivity and allergen‐induced Langerhans cell migration in murine epidermis , 2008, Journal of leukocyte biology.

[46]  J. Nicolas,et al.  Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells. , 2010, The Journal of allergy and clinical immunology.

[47]  J. Kehren,et al.  Skin Inflammation During Contact Hypersensitivity Is Mediated by Early Recruitment of CD8+ T Cytotoxic 1 Cells Inducing Keratinocyte Apoptosis1 , 2002, The Journal of Immunology.

[48]  G Frank Gerberick,et al.  Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[49]  J. Nicolas,et al.  Depletion of human peripheral blood lymphocytes in CD25+ cells allows for the sensitive in vitro screening of contact allergens. , 2008, The Journal of investigative dermatology.

[50]  F. Sallusto,et al.  Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells , 2009, The Journal of experimental medicine.

[51]  M. Goebeler,et al.  Nickel allergies: paying the Toll for innate immunity , 2011, Journal of Molecular Medicine.

[52]  Silvia Casati,et al.  Selection of Chemicals for the Development and Evaluation of In Vitro Methods for Skin Sensitisation Testing , 2009 .

[53]  Malin Lindstedt,et al.  A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests , 2011, BMC Genomics.

[54]  M. Hahne,et al.  Cytotoxicity Is Mandatory for CD8+ T Cell–mediated Contact Hypersensitivity , 1999, The Journal of experimental medicine.

[55]  T. D. de Gruijl,et al.  Epidermis‐to‐dermis migration of immature Langerhans cells upon topical irritant exposure is dependent on CCL2 and CCL5 , 2010, European journal of immunology.

[56]  Hilda Witters,et al.  Assessment of chemical skin-sensitizing potency by an in vitro assay based on human dendritic cells. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[57]  Takao Ashikaga,et al.  Assessment of the human Cell Line Activation Test (h-CLAT) for Skin Sensitization; Results of the First Japanese Inter-laboratory Study , 2008 .

[58]  Petra S Kern,et al.  The incorporation of lysine into the peroxidase peptide reactivity assay for skin sensitization assessments. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[59]  H. Okamura,et al.  Cloning of a new cytokine that induces IFN-γ production by T cells , 1995, Nature.

[60]  T. Jakob,et al.  Mechanisms of chemical‐induced innate immunity in allergic contact dermatitis , 2011, Allergy.

[61]  M. Schnölzer,et al.  Tracking human contact allergens: from mass spectrometric identification of peptide-bound reactive small chemicals to chemical-specific naive human T-cell priming. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[62]  H. Sakaguchi,et al.  Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[63]  Detlef Keller,et al.  Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation. , 2012, Regulatory toxicology and pharmacology : RTP.

[64]  J. Hooyberghs,et al.  Gene markers in dendritic cells unravel pieces of the skin sensitization puzzle. , 2010, Toxicology letters.

[65]  C. Kirkpatrick,et al.  Primary human coculture model of alveolo-capillary unit to study mechanisms of injury to peripheral lung , 2009, Cell and Tissue Research.

[66]  Jean Kanitakis,et al.  Contact dermatitis II. Clinical aspects and diagnosis. , 1999, European journal of dermatology : EJD.

[67]  H. Merk,et al.  A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. , 2007, The Journal of investigative dermatology.

[68]  Takao Ashikaga,et al.  Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[69]  H. Weltzien,et al.  Novel fluorescence assay for tracking molecular and cellular allergen-protein interactions. , 2007, Journal of immunological methods.

[70]  E. Corsini,et al.  Role of p38 MAPK in the selective release of IL-8 induced by chemical allergen in naive THp-1 cells. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[71]  Hiroshi Itagaki,et al.  A Comparative Evaluation of In Vitro Skin Sensitisation Tests: The Human Cell-line Activation Test (h-CLAT) versus the Local Lymph Node Assay (LLNA) , 2010, Alternatives to laboratory animals : ATLA.

[72]  Emanuela Corsini,et al.  Chemical Respiratory Allergy: Opportunities for Hazard Identification and Characterisation , 2007, Alternatives to laboratory animals : ATLA.

[73]  H. Merk,et al.  Cytochrome P450-mediated activation of the fragrance compound geraniol forms potent contact allergens. , 2008, Toxicology and applied pharmacology.

[74]  I. Kimber,et al.  Interleukin (IL)‐18 induces Langerhans cell migration by a tumour necrosis factor‐α‐ and IL‐1β‐dependent mechanism , 2001, Immunology.

[75]  F. Bérard,et al.  Skin-Infiltrating CD8+ T Cells Initiate Atopic Dermatitis Lesions1 , 2007, The Journal of Immunology.

[76]  H. Sakaguchi,et al.  Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[77]  Horst Wenck,et al.  In vitro detection of contact allergens: development of an optimized protocol using human peripheral blood monocyte-derived dendritic cells. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[78]  B. K. Park,et al.  Role of protein haptenation in triggering maturation events in the dendritic cell surrogate cell line THP-1. , 2009, Toxicology and applied pharmacology.

[79]  J. Lepoittevin,et al.  Nuclear magnetic resonance studies on covalent modification of amino acids thiol and amino residues by monofunctional aryl 13C-isocyanates, models of skin and respiratory sensitizers: transformation of thiocarbamates into urea adducts. , 2009, Chemical research in toxicology.

[80]  S. Garcovich,et al.  IL-17 Amplifies Human Contact Hypersensitivity by Licensing Hapten Nonspecific Th1 Cells to Kill Autologous Keratinocytes , 2010, The Journal of Immunology.